Skip to main content
    L

    Lineage Cell Therapeutics Inc (LCTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.82
    +0.02 (+2.99%)

    Market Cap: $201.12M

    Last updated: Nov 17, 2026 at 4:23 PM ET

    Lineage Cell Therapeutics Inc (LCTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Lineage Cell Therapeutics (LCTX) has a latest price of $0.82 on Nov 17, 2026, 58.7% below its 52-week high of $1.99. Its price fell 56.4% over the past 12 months. The month-end price fell 68.9% over the 10 years through Oct 2026, a compound annual decline of 11.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $3.61 in Dec 2016 and its lowest $0.45 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart LCTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LCTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.6%, and over 6 months it fell 31.8%. The month-end price fell 12.3% over the 3 years through Oct 2026, a compound annual decline of 4.3%.

    PeriodChange
    1 month-14.1%
    3 months-25.6%
    6 months-31.8%
    12 months-56.4%
    12 months, with dividends-56.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-12.3%-4.3%
    5 years-56.1%-15.2%
    10 years-68.9%-11.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 232.3%, and its weakest was 2018, when it fell 57.5%.

    YearCloseChange
    2026 through Oct 2026$1.00-40.1%
    2025$1.67+232.3%
    2024$0.50-53.9%
    2023$1.09-6.8%
    2022$1.17-52.2%
    2021$2.45+39.2%
    2020$1.76+97.8%
    2019$0.89-2.5%
    2018$0.91-57.5%
    2017$2.15-40.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 17.0% below its 50-day average of $0.99 and 36.5% below its 200-day average of $1.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.82
    52-week high$1.99-58.7%
    52-week low$0.77+6.4%
    50-day average$0.99-17.0%
    200-day average$1.29-36.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 73.9%.

    MeasureValue
    1-year beta1.27
    Largest fall, 1 year-59.4%
    Largest fall, 3 years-73.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About LCTX

    What is LCTX's 1-year price change?

    Lineage Cell Therapeutics's price fell 56.4% over the past 12 months. With dividends included, the 12-month total return was -56.4%.

    What is LCTX's 5-year price change?

    Lineage Cell Therapeutics's month-end price fell 56.1% over the 5 years through Oct 2026, a compound annual decline of 15.2%. These figures leave out dividends.

    What is LCTX's 52-week high and low?

    Lineage Cell Therapeutics's 52-week high is $1.99 and its 52-week low is $0.77. Its latest price of $0.82 on Nov 17, 2026 is 58.7% below the high.

    What is LCTX's beta?

    Lineage Cell Therapeutics's 1-year beta against the S&P 500 is 1.27, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.4%.

    Is the LCTX chart free?

    Yes. Advanced Charting for LCTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.